Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis

Kidney International
Nosratola D Vaziri, K Liang

Abstract

Increased production and depressed catabolism of lipoproteins play major roles in the pathogenesis of hypercholesterolemia of nephrotic syndrome (NS). However, the effect, if any, of NS on cholesterol biosynthetic capacity is uncertain. We examined the gene expression of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoAR, the rate limiting step in cholesterol biosynthesis) during the induction and chronic phase of puromycin (PAN)-induced NS in rats. The rats were randomized to NS (given i.p. puromycin aminonucleoside 130 mg/kg on day 1 and 60 mg/kg on day 14) and placebo-treated control groups. Subgroups of animals were sacrificed at days 5, 10, 20 and 30. The liver was harvested between 7 and 9 p.m. for measurements of HMG-CoAR and actin mRNAs, HMG-CoAR enzymatic activity and microsomal cholesterol concentration. In separate experiments, subgroups of animals with chronic NS (day 30) were studied in fed and 20-hour fasting states. A marked but transient rise in hepatic HMG-CoAR mRNA and HMG-CoAR enzymatic activity was observed following the onset and exacerbation of proteinuria within a few days after each puromycin injection. On each occasion, HMG-CoAR fell to the baseline level despite persistent severe hypercholester...Continue Reading

References

Jul 1, 1977·Kidney International·A C GoldbergE C Quintão
May 26, 1992·Biochemistry·D W Russell, K D Setchell
Mar 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Z R VlahcevicP B Hylemon
Feb 1, 1990·Metabolism: Clinical and Experimental·G L WarwickJ Shepherd
Aug 30, 1990·The New England Journal of Medicine·J JovenM Vallés
Nov 1, 1987·Kidney International·J R Diamond, M J Karnovsky
May 1, 1987·Metabolism: Clinical and Experimental·I StapransW G Couser
Oct 1, 1984·The Journal of Clinical Investigation·D W GarberC E Sparks
May 1, 1984·Archives of Biochemistry and Biophysics·T R WhiteheadP B Hylemon
Nov 1, 1993·Kidney International·P StenvinkelA Alvestrand
Aug 1, 1954·The American Journal of Physiology·S O BYERSR H ROSENMAN
Jan 1, 1961·Proceedings of the Society for Experimental Biology and Medicine·U DUBACHM B KOCH

❮ Previous
Next ❯

Citations

Feb 21, 1998·Lipids·A KambeY Adachi
Mar 21, 1998·Lipids·A al-ShurbajiL Berglund
Jul 21, 1999·Kidney International. Supplement·V S KamannaD D Roh
Apr 23, 2002·Kidney International·Nosratola D Vaziri, Kaihui Liang
Apr 5, 2003·Kidney International·Nosratola D Vaziri
Apr 29, 1998·The New England Journal of Medicine·S R Orth, E Ritz
Apr 5, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nosratola D VaziriHamid Moradi
Dec 19, 2009·Seminars in Dialysis·Nosratola D Vaziri
Jul 11, 2008·American Journal of Physiology. Renal Physiology·Yunfeng ZhouYoufei Guan
Oct 26, 2012·Journal of Atherosclerosis and Thrombosis·William F KeaneDavid R Neff
Oct 30, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Shuman Liu, Nosratola D Vaziri
Jul 16, 2004·Kidney International·Bernardo Rodríguez-IturbeNosratola D Vaziri
Oct 2, 2004·Kidney International·Christian K RobertsNosratola D Vaziri
Mar 1, 1997·Kidney International·N D Vaziri, K Liang
Jun 1, 1997·Kidney International·K Liang, N D Vaziri
Jun 1, 1997·Kidney International·K Liang, N D Vaziri
Sep 1, 1996·Kidney International·N D Vaziri, K H Liang
May 11, 2010·Prostaglandins & Other Lipid Mediators·Maho WatanabeTakao Saito
Sep 22, 2007·Metabolism: Clinical and Experimental·Choong H KimNosratola D Vaziri
Jan 31, 2006·Hemodialysis International·Nosratola D Vaziri, Hamid Moradi
Sep 5, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Allison B ReissJoseph Mattana
May 1, 1997·Renal Failure·M E Ibarra-RubioJ Pedraza-Chaverrí
May 12, 2016·Kidney International·Nosratola D Vaziri
Oct 28, 2004·The Annals of Pharmacotherapy·William A PrescottDaniel S Streetman
Nov 28, 2017·Nature Reviews. Nephrology·Shipra AgrawalWilliam E Smoyer
Dec 9, 2004·American Journal of Physiology. Endocrinology and Metabolism·Sara KimNosratola D Vaziri
Jul 21, 2005·American Journal of Physiology. Endocrinology and Metabolism·Youngshin ShinJaap A Joles
Aug 3, 2005·Medicinal Research Reviews·Michele BuemiNicola Frisina
Jan 13, 2006·American Journal of Physiology. Renal Physiology·N D Vaziri
Jul 29, 2004·American Journal of Physiology. Renal Physiology·N D Vaziri, K Liang
Apr 9, 2001·American Journal of Physiology. Renal Physiology·N D VaziriJ S Parks
May 1, 2021·Life·Carlo Maria BarbagalloEmilio Nardi
Nov 14, 1997·The Journal of Laboratory and Clinical Medicine·K Liang, N D Vaziri
Apr 14, 2005·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Florian Kronenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

The Journal of Laboratory and Clinical Medicine
K Liang, Nosratola D Vaziri
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
K Liang, Nosratola D Vaziri
© 2021 Meta ULC. All rights reserved